Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy

Journal of Cardiovascular Medicine

Volumn 11, Issue 11, 2010, Pages 795-800

  Patti, Giuseppe ^a   Chello, Massimo ^a   Gatto, Laura ^a   Alfano, Gennaro ^b   Miglionico, Marco ^a   Covino, Elvio ^a   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

acute coronary syndromes; adhesion molecules; atorvastatin; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; TROPONIN I; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; AGED; ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; INFLAMMATION; LOADING DRUG DOSE; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; CADHERINS; CELL ADHESION MOLECULES; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PLACEBO EFFECT; PROSPECTIVE STUDIES; PYRROLES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77958157904     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833b929c     Document Type: Article

References (24)

1. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G, ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004; 110:674-678. (Pubitemid 39056265)
2. Patti G, Chello M, Pasceri V, Colonna D, Nusca A, Miglionico M, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol 2006; 48:1560-1566. (Pubitemid 44528186)
3. Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, et al. Atorvastatin pretreatment improves outcome in patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Results of the ARMYDA-ACS (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Acute Coronary Syndromes) randomized trial. J Am Coll Cardiol 2007; 49:1272-1278.
4. Patti G, Colonna G, Pasceri V, Lassandro Pepe L, Montinaro A, Di Sciascio G. A randomized trial of high loading dose of clopidogrel for reduction of peri-procedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005; 111:2099-2106. (Pubitemid 40577905)
5. Uettwiller-Geiger D,WuAH, Apple FS, JevansAW, Venge P, OlsonMD, et al. Multicenter evaluation of an automated assay for troponin. Clin Chem 2002; 48:869-876. (Pubitemid 34587586)
6. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-969.
7. Jones SP, Lefer DJ. Cardioprotective actions of acute HMG-CoA reductase inhibition in the setting of myocardial infarction. Acta Physiol Scand 2001; 173:139-143.
8. Ray KK, Cannon CP. The potential relevance of the multiple lipidindependent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol 2005; 46:1425-1433.
9. Leeuwenberg JF, Smeets EF, Neefjes JJ, Shaffer MA, Cinek T, Jeunhomme TM, et al. E-selectin and inter-cellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992; 77:543-549. (Pubitemid 23000475)
10. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88:1121-1127.
11. Omori H, Nagashima H, Tsurumi Y, Takagi A, Ishizuka N, Hagiwara N, et al. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol 2002; 54:395-399. (Pubitemid 35334952)
12. Hinoi T, Matsuo S, Tadehara F, Tsujiyama S, Yamakido M. Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography. Am J Cardiol 2005; 96:89-91. (Pubitemid 40853947)
13. LaufsU,LaFataV,PlutzkyJ,LiaoJK.Upregulationofendothelial nitricoxidesynthase byHMGCoA reductase inhibitors. Circulation 1998; 97:1129-1135. (Pubitemid 28152885)
14. Bonetti PO, Lerman LO, Napoli C, Lerman A. Statin effects beyond lipid lowering: are they clinically relevant? Eur Heart J 2003; 24:225-248. (Pubitemid 36207079)
15. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92:1866-1874. (Pubitemid 23304554)
16. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous Coronary Intervention. Results of the ARMYDARECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol 2009; 54:558-565.
17. Moliterno DJ, Penn MS. Angioplasty, inflammation and antiplatelet agents. Am Heart J 2003; 145:563-566.
18. Campbell B, Chuhran CM, Lefer DJ, Lefer AM. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion. Methods Find Exp Clin Pharmacol 1999; 21:529-534. (Pubitemid 29535808)
19. Nannizzi-Alaimo L, Alves VL, Phillips DR. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation 2003; 107:1123-1128. (Pubitemid 36297203)
20. Voisard R, Alan M, von Müller L, Baur R, Hombach V. Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPLratio. BMC Cardiovasc Disord 2006; 6:14-21. (Pubitemid 43842142)
21. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, Kolodziej B, Naruszewicz M. SimvastatinmodulatesTNFalpha-induced adhesionmolecules expression in human endothelial cells. Life Sciences 2004; 75:1287-1302. (Pubitemid 38845028)
22. Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G, Molteni R, et al. Statins prevent endothelial cell activation induced by antiphospholipid (antibeta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001; 44:2870-2878. (Pubitemid 34016207)
23. Wagner AH, Gebauer M, Guldenzoph B, Hecker M. 3-hydroxy-3- methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells. Arterioscler Thromb Vasc Biol 2002; 22:1784-1789. (Pubitemid 35315762)
24. Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by antiatherosclerosis drugs. Circulation 2001; 103:2531-2534. (Pubitemid 32521959)